# Autonomous Agentic AFTERNOON Swing/Rotation Scan — 2026-08-04

- Decision window: approximately 17:33–17:36 UTC / 13:33–13:36 ET
- Account: Robinhood Agentic 433711041 / ending 1041 only
- Policy: `playbook/autonomous-policy.md` ACTIVE and loaded with the `robinhood-trading-operator` skill
- Scope: long fractional equities only; no options, shorts, other accounts, averaging down, or stop widening
- Decision: **HOLD AVGO, MA, BAC; NO ROTATION; NO NEW ORDER.**

## Live broker state and safety gates

- Identity verified live: account 433711041 is the active cash/individual account nicknamed Agentic and is the only account with `agentic_allowed=true`; no other account was operated.
- Account value: **$326.4670**; equity value **$171.1970**; cash ledger **$155.27**; authoritative liquid buying power **$9.85**; unsettled funds **$145.42**; pending deposits $0.
- Open positions: AVGO 0.095750 @ $411.28 average; MA 0.113541 @ $572.48; BAC 1.046363 @ $62.12. Every share is available to sell.
- All required open-ish equity states were queried: `new`, `queued`, `confirmed`, `unconfirmed`, and `partially_filled`; every state was empty. Pending-order commitment: **$0**.
- Recent same-day fills were verified: AVGO buy 0.095750 @ $411.278 for $39.38; SHEL full sell 0.908550 @ $89.0701; XOM full sell 0.431232 @ $149.5801. All were agentic, filled, and charged $0 fees.
- Today's realized equity P&L: **-$3.90** across the XOM/SHEL exits. Thirty-day realized equity P&L: **-$19.08**; this is realized-trade P&L, not total portfolio performance.
- Kill switch clear: value is above $10 and broker/account/order/quote/risk data are coherent.
- Drawdown pauses clear: account value is approximately **-0.85%** versus the Aug. 3 power-hour value $329.2761 and **-0.89%** versus the comparable recent high $329.39, below the 5% daily and 10% recent-high pause thresholds.

## Market, macro, and sector regime

Live at approximately 13:36 ET:

- SPY **$771.47 (+1.82%)**, QQQ **$722.37 (+3.19%)**, IWM **$301.85 (+1.90%)**. SPY and IWM are above rising completed 10/20/50-day averages; QQQ has reclaimed its completed 50-day area (~$714.83).
- Leadership remains highly concentrated: SMH **+5.60%** and XLK **+5.00%**. XLI **+1.73%** and XLF **+0.98%** provide positive secondary breadth.
- Lagging/defensive flow: XLE **-0.32%**, XLV **-0.16%**, XLY **+0.25%**, and XLP **+0.26%**. The prior energy-relative-strength thesis remains invalidated.
- Regime: **strong risk-on, but AI/semiconductor and earnings-gap driven**. Broad indexes confirm risk appetite, while extreme single-name extensions and tonight's AMD earnings create poor chase geometry and reversal/event risk.
- Current catalyst context: PLTR's Q2 revenue rose 93% year over year to about $1.94B, EPS beat, and full-year guidance increased materially. Networking/AI semiconductor demand supports AVGO/MRVL/NVDA, while oil weakness amid renewed Middle East diplomacy supports the energy rotation already executed this morning.

## Existing-position management

### AVGO — HOLD; no add or trim

- Live **$419.69 (+7.00% day)**; value **$40.19**; unrealized **+$0.81 (+2.04%)**.
- Technical: above the prior 20-day high $407.52 and completed SMA10/20/50 $386.15/$385.65/$394.80; prior-day RSI14 ~52.7. SMH +5.60% confirms relative strength. Immediate resistance/target is $430, then $445; breakout support is $407.50–$411.
- Fundamental: latest quarterly revenue $22.187B, net income $9.31B, and 41.96% net margin; AI/custom-silicon and networking demand remain supportive. Verified next earnings Sep. 2 after close. Valuation (~64.8 trailing P/E) and AI-capex concentration remain risks.
- Binding invalidation **$400.50**; targets **$430/$445**. Quote-based risk to stop **~$1.84**. No stop widening. A trim is not justified before $430 while breakout/sector confirmation persists.

### MA — HOLD

- Live **$571.98 (+0.18% day)**; value **$64.94**; unrealized **-$0.06 (-0.09%)**.
- Technical: above rising SMA10/20/50 $553.94/$544.72/$515.59; prior-day RSI14 ~67.7. Support/invalidation $560; resistance $582.62, then target $596.
- Fundamental: Q2 EPS $5.04 beat $4.76; revenue $9.277B and net margin 47.3%, with continued profitable payment-volume exposure. Next earnings is tentative Oct. 29.
- Binding invalidation **$560**; target **$596**. Quote-based risk **~$1.36**, reward **~$2.73**, live R:R ~2.01:1. Thesis unchanged; no add below cost.

### BAC — HOLD

- Live **$63.22 (+1.18% day)**; value **$66.15**; unrealized **+$1.15 (+1.77%)**.
- Technical: session high/52-week high $63.54; above SMA10/20/50 ~$61.82/$61.01/$57.47 with prior-day RSI14 ~64.8. Support/invalidation $60.80; resistance $63.54, then target $64.90.
- Fundamental: Q2 EPS $1.21 beat $1.11; revenue $31.558B, net income $9.074B, net margin 28.75%, and dividend increased 14% to $0.32. XLF +0.98% confirms sector participation. Next verified earnings Oct. 14.
- Binding invalidation **$60.80**; target **$64.90**. Quote-based risk **~$2.53**. Hold while breakout structure persists; do not add at the 52-week high.

- Aggregate quote-based planned risk to scan-managed invalidations: **~$5.73**, under the policy's ~$6 default target. Stops are scan-managed and gap risk can exceed estimates.

## Broad liquid universe and ranked opportunities

The scan used live Robinhood saved scanners and popular-list constituents, earnings calendar/results, live benchmark/sector/candidate quotes, fractional tradability, daily OHLCV/ATR/RSI, current fundamentals/quarterly financials, and current macro/company news. It did not depend on stale personal watchlists.

1. **AVGO — 8.7/10, HOLD EXISTING.** Best live alignment of liquidity, breakout confirmation, sector leadership, revenue growth, margins, and a defined $400.50 invalidation. No add because the position already implements today's 80% liquid-deployment decision and the remaining buying power is the required reserve.
2. **NVDA — 8.0/10, WATCH; NO ENTRY.** Live $211.32 (+2.26%), above SMA10/20 but below the $214.39 20-day high. Trigger requires a confirmed hold above $214.40; support/invalidation near $206, targets $228/$236.50. Revenue rose to $81.615B with exceptional profitability, but an entry now duplicates AVGO/SMH exposure, lacks breakout confirmation, and verified earnings Aug. 26 adds event risk.
3. **MA — 7.8/10, HOLD EXISTING.** High-margin quality and rising daily trend with a clear $560 invalidation and ~$596 target. It diversifies the concentrated chip exposure, but there is no reason to add while it remains around cost and the cash reserve is already correctly sized.
4. **BAC — 7.6/10, HOLD EXISTING.** Fresh 52-week-high test, positive XLF flow, strong Q2 results, and improving dividend. No new entry at resistance; existing target $64.90 remains intact.
5. **PLTR — 7.4/10, NO CHASE.** Live $161.74 (+28.72%), session $143.28–$162.83, with volume over 3x normal after exceptional Q2 growth and raised guidance. The catalyst is real, but ~138.6 P/E, a $19.55 intraday range, and no base/retest prevent a clean stop and minimum-R:R swing. Watch a multi-session base or controlled retest.
6. **MRVL — 7.1/10, NO CHASE.** Live $221.54 (+14.33%), session support ~$208 and resistance $222.57. AI/networking exposure and revenue growth are positive, but the prior close remained below SMA20/50, ATR was ~8.84%, latest reported net margin was only 1.43%, and verified earnings are Aug. 27. Wait for a multi-day base/retest.
7. **ZBRA/CAT — 6.8/6.6, WAIT.** ZBRA $356.10 (+22.10%) after EPS $6.35 vs $4.20 and at a fresh 52-week high; CAT $886.58 (+6.81%) after EPS $8.17 vs $6.17. Both have legitimate earnings catalysts, but their gap ranges ($329.47–$360.87 and $866.85–$935.00) are too wide for clean small-account swing invalidations without chasing.
8. **AMD — EXCLUDED.** Live $525.54 (+8.44%) but reports after today's close. No new overnight event-risk entry is permitted without a separately justified earnings plan.

No candidate materially improves the current portfolio's risk-adjusted setup enough to justify churn or spending the reserve.

## Deployment, actions, and final decision

- Authoritative liquid buying power after pending orders: **$9.85**; pending-order commitment $0.
- Earlier today, AVGO deployed **$39.38**, exactly 80% rounded of the then-available $49.23, leaving **$9.85 (20.01%)** as the policy reserve. Reapplying 80% recursively to that reserve would defeat the required 20% cash buffer.
- New deployment this scan: **$0**. Cash reserve retained: **$9.85 spendable**, plus **$145.42 unsettled/non-spendable proceeds** in the $155.27 cash ledger.
- Existing equity exposure: **$171.20 / $326.47 = 52.44%** of account value; this counts separately from available liquid buying power per policy.
- No intended order passed decision quality; therefore no order review or placement was submitted. No rotation, exit, cancellation, option, short, other-account action, averaging down, or stop widening occurred.
- Final instruction: hold AVGO/MA/BAC under the invalidations and targets above; reassess at the scheduled power-hour scan or immediately on a thesis/stop breach.
